Form4.ai tracks every SEC insider trade in real time. See every OKYO insider filing with a free account — no card.
See every OKYO insider filing — free account, no card.
Free accountOKYO Pharma Ltd (OKYO) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 7 insider purchases totalling $136K. Most recent filing: Aug. 7, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Aug 7, 2026 SEC filing Amended: Corrected by the insider on Aug 7, 2026 | JACOB GARY S CHIEF DEVELOPMENT OFFICER | Bought | $4,900 | 0.0% 90D |
| Aug 7, 2026 SEC filing Amended: Corrected by the insider on Aug 7, 2026 | Dempsey Robert John CHIEF EXECUTIVE OFFICER | Bought | $23,085 | -11.0% 90D |
| Aug 7, 2026 SEC filing Amended: Corrected by the insider on Aug 7, 2026 | BRANCACCIO JOHN P Director | Bought | $7,385 | -5.2% 90D |
Create a free account to see all 7 OKYO filings from the last 90 days. No card needed.
Create free accountWant OKYO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.